Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Mackness

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|March 13, 2002
Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dipNicola Cherry, Mike Mackness, Paul Durrington, et al.
Pharmacogenetics|February 4, 2003
Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheepBharti Mackness, Paul Durrington, Andrew Povey, et al.
Clinical Endocrinology|June 10, 2005
The effect of atorvastatin on serum lipoproteins in acromegalyManoj Mishra, Paul Durrington, Mike Mackness, et al.
Disease Markers|March 21, 2022
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-AnalysisMarco Zuin, Alessandro Trentini, Judit Marsillach, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 21, 2023
Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?Abdolkarim Mahrooz, Omeh Farveh Khosravi-Asrami, Ahad Alizadeh, et al.
Circulation|April 2, 2003
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosisAnn Mertens, Peter Verhamme, John K Bielicki, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
European Journal of Clinical Investigation|October 23, 2010
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaquesJudit Marsillach, Jordi Camps, Raul Beltran-Debón, et al.
Chemico-Biological Interactions|February 23, 2017
Transcriptional regulation of human Paraoxonase 1 by nuclear receptorsN Ponce-Ruiz, F E Murillo-González, A E Rojas-García, et al.
Archives of Medical Sciences. Atherosclerotic Diseases|June 19, 2019
PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkersFátima E Murillo González, Néstor Ponce-RuÍz, Aurora E Rojas-GarcÍa, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 13, 2002
Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dipNicola Cherry, Mike Mackness, Paul Durrington, et al.
Pharmacogenetics|February 4, 2003
Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheepBharti Mackness, Paul Durrington, Andrew Povey, et al.
Clinical Endocrinology|June 10, 2005
The effect of atorvastatin on serum lipoproteins in acromegalyManoj Mishra, Paul Durrington, Mike Mackness, et al.
Disease Markers|March 21, 2022
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-AnalysisMarco Zuin, Alessandro Trentini, Judit Marsillach, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 21, 2023
Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?Abdolkarim Mahrooz, Omeh Farveh Khosravi-Asrami, Ahad Alizadeh, et al.
Circulation|April 2, 2003
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosisAnn Mertens, Peter Verhamme, John K Bielicki, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
European Journal of Clinical Investigation|October 23, 2010
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaquesJudit Marsillach, Jordi Camps, Raul Beltran-Debón, et al.
Chemico-Biological Interactions|February 23, 2017
Transcriptional regulation of human Paraoxonase 1 by nuclear receptorsN Ponce-Ruiz, F E Murillo-González, A E Rojas-García, et al.
Archives of Medical Sciences. Atherosclerotic Diseases|June 19, 2019
PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkersFátima E Murillo González, Néstor Ponce-RuÍz, Aurora E Rojas-GarcÍa, et al.
Pageof 4